Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma

Glioblastoma multiforme (GBM) is a severe brain tumor whose ability to mutate and adapt to therapies is at the base for the extremely poor survival rate of patients. Despite multiple efforts to develop alternative forms of treatment, advances have been disappointing and GBM remains an arduous tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Alessandra, Stagni, Venturina, Barilà, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402284/
https://www.ncbi.nlm.nih.gov/pubmed/32664581
http://dx.doi.org/10.3390/ijms21144910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402284/
https://www.ncbi.nlm.nih.gov/pubmed/32664581
http://dx.doi.org/10.3390/ijms21144910

Ejemplares similares